Literature DB >> 19458064

Alteration in plasma testosterone levels in male mice lacking soluble epoxide hydrolase.

Ayala Luria1, Christophe Morisseau, Hsing-Ju Tsai, Jun Yang, Bora Inceoglu, Bart De Taeye, Steven M Watkins, Michelle M Wiest, J Bruce German, Bruce D Hammock.   

Abstract

Soluble epoxide hydrolase (Ephx2, sEH) is a bifunctional enzyme with COOH-terminal hydrolase and NH(2)-terminal phosphatase activities. sEH converts epoxyeicosatrienoic acids (EETs) to dihydroxyeicosatrienoic acids (DHETs), and the phosphatase activity is suggested to be involved in cholesterol metabolism. EETs participate in a wide range of biological functions, including regulation of vascular tone, renal tubular transport, cardiac contractility, and inflammation. Inhibition of sEH is a potential approach for enhancing the biological activity of EETs. Therefore, disruption of sEH activity is becoming an attractive therapeutic target for both cardiovascular and inflammatory diseases. To define the physiological role of sEH, we characterized a knockout mouse colony lacking expression of the Ephx2 gene. Lack of sEH enzyme is characterized by elevation of EET to DHET ratios in both the linoleate and arachidonate series in plasma and tissues of both female and male mice. In male mice, this lack of expression was also associated with decreased plasma testosterone levels, sperm count, and testicular size. However, this genotype was still able to sire litters. Plasma cholesterol levels also declined in this genotype. Behavior tests such as anxiety-like behavior and hedonic response were also examined in Ephx2-null and WT mice, as all can be related to hormonal changes. Null mice showed a level of anxiety with a decreased hedonic response. In conclusion, this study provides a broad biochemical, physiological, and behavioral characterization of the Ephx2-null mouse colony and suggests a mechanism by which sEH and its substrates may regulate circulating levels of testosterone through cholesterol biosynthesis and metabolism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19458064      PMCID: PMC2724109          DOI: 10.1152/ajpendo.00131.2009

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  54 in total

1.  Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone.

Authors:  Steven M Watkins; Peter R Reifsnyder; Huei-ju Pan; J Bruce German; Edward H Leiter
Journal:  J Lipid Res       Date:  2002-11       Impact factor: 5.922

2.  Engaging in paced mating, but neither exploratory, anti-anxiety, nor social behavior, increases 5alpha-reduced progestin concentrations in midbrain, hippocampus, striatum, and cortex.

Authors:  Cheryl A Frye; Jason J Paris; Madeline E Rhodes
Journal:  Reproduction       Date:  2007-03       Impact factor: 3.906

3.  Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

Authors:  Christophe Morisseau; Marvin H Goodrow; John W Newman; Craig E Wheelock; Deanna L Dowdy; Bruce D Hammock
Journal:  Biochem Pharmacol       Date:  2002-05-01       Impact factor: 5.858

4.  Home cage activity and activity-based measures of anxiety in 129P3/J, 129X1/SvJ and C57BL/6J mice.

Authors:  Xiangdong Tang; Larry D Sanford
Journal:  Physiol Behav       Date:  2004-12-08

5.  Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice.

Authors:  F Pinot; D F Grant; J L Spearow; A G Parker; B D Hammock
Journal:  Biochem Pharmacol       Date:  1995-08-08       Impact factor: 5.858

6.  The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activity.

Authors:  John W Newman; Christophe Morisseau; Todd R Harris; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-06       Impact factor: 11.205

7.  Cytosolic and microsomal epoxide hydrolases are immunologically distinguishable from each other in the rat and mouse.

Authors:  T M Guenthner; B D Hammock; U Vogel; F Oesch
Journal:  J Biol Chem       Date:  1981-04-10       Impact factor: 5.157

8.  Pharmacological evaluation of an epoxide as the putative hyperpolarizing factor mediating the nitric oxide-independent vasodilator effect of bradykinin in the rat heart.

Authors:  D Fulton; J C Mcgiff; J Quilley
Journal:  J Pharmacol Exp Ther       Date:  1998-11       Impact factor: 4.030

9.  Bioactivation of leukotoxins to their toxic diols by epoxide hydrolase.

Authors:  M F Moghaddam; D F Grant; J M Cheek; J F Greene; K C Williamson; B D Hammock
Journal:  Nat Med       Date:  1997-05       Impact factor: 53.440

10.  Tetrahydrofurandiols (THF-diols), leukotoxindiols (LTX-diols), and endocrine disruption in rats.

Authors:  Barry M Markaverich; Mary Alejandro; Trellis Thompson; Shaila Mani; Andrea Reyna; Wendy Portillo; John Sharp; John Turk; Jan R Crowley
Journal:  Environ Health Perspect       Date:  2007-01-29       Impact factor: 9.031

View more
  21 in total

1.  Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer.

Authors:  Paula Vainio; Santosh Gupta; Kirsi Ketola; Tuomas Mirtti; John-Patrick Mpindi; Pekka Kohonen; Vidal Fey; Merja Perälä; Frank Smit; Gerald Verhaegh; Jack Schalken; Kalle A Alanen; Olli Kallioniemi; Kristiina Iljin
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Pharmacological inhibition of soluble epoxide hydrolase or genetic deletion reduces diclofenac-induced gastric ulcers.

Authors:  Sumanta Kumar Goswami; Amelia Ann Rand; Debin Wan; Jun Yang; Bora Inceoglu; Melany Thomas; Christophe Morisseau; Guang-Yu Yang; Bruce D Hammock
Journal:  Life Sci       Date:  2017-05-15       Impact factor: 5.037

3.  Role of soluble epoxide hydrolase phosphatase activity in the metabolism of lysophosphatidic acids.

Authors:  Christophe Morisseau; Nils Helge Schebb; Hua Dong; Arzu Ulu; Pavel A Aronov; Bruce D Hammock
Journal:  Biochem Biophys Res Commun       Date:  2012-02-24       Impact factor: 3.575

4.  Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance.

Authors:  Ayala Luria; Ahmed Bettaieb; Yannan Xi; Guang-Jong Shieh; Hsin-Chen Liu; Hiromi Inoue; Hsing-Ju Tsai; John D Imig; Fawaz G Haj; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-12       Impact factor: 11.205

5.  Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.

Authors:  Sumanta Kumar Goswami; Debin Wan; Jun Yang; Carlos A Trindade da Silva; Christophe Morisseau; Sean D Kodani; Guang-Yu Yang; Bora Inceoglu; Bruce D Hammock
Journal:  J Pharmacol Exp Ther       Date:  2016-03-17       Impact factor: 4.030

6.  Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.

Authors:  Karen Wagner; Jun Yang; Bora Inceoglu; Bruce D Hammock
Journal:  J Pain       Date:  2014-06-09       Impact factor: 5.820

7.  Sex steroid levels and AD-like pathology in 3xTgAD mice.

Authors:  Cassia R Overk; Sylvia E Perez; Chunqi Ma; Matthew D Taves; Kiran K Soma; Elliott J Mufson
Journal:  J Neuroendocrinol       Date:  2013-02       Impact factor: 3.627

Review 8.  Soluble epoxide hydrolase: gene structure, expression and deletion.

Authors:  Todd R Harris; Bruce D Hammock
Journal:  Gene       Date:  2013-05-20       Impact factor: 3.688

9.  Development of an HTS assay for EPHX2 phosphatase activity and screening of nontargeted libraries.

Authors:  Christophe Morisseau; Sunil Sahdeo; Gino Cortopassi; Bruce D Hammock
Journal:  Anal Biochem       Date:  2012-12-03       Impact factor: 3.365

10.  Heavy chain single-domain antibodies to detect native human soluble epoxide hydrolase.

Authors:  Yongliang Cui; Dongyang Li; Christophe Morisseau; Jie-Xian Dong; Jun Yang; Debin Wan; Martín A Rossotti; Shirley J Gee; Gualberto G González-Sapienza; Bruce D Hammock
Journal:  Anal Bioanal Chem       Date:  2015-07-31       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.